Felix L. Naegele

Nov 20, 2024 | medrxiv.org | Felix L. Naegele |Anke Wouters |Marlene Heinze |Lauranne Scheldeman

F.L.N., L.S., A.W., M.H., M.P., E.S., M.S., M. Ebinger, R.L., N.N., S.P., J.P., V.T., and B.C. declare no conflicts of interest in relation to this study. L.S. reports fees for congress participation from Angelini Pharma outside the submitted work. M. Endres reports grants from Bayer and fees paid to the Charite from Amgen, Astra-Zeneca, Bayer Healthcare, Boehringer Ingelheim, BMS, Daiichi Sankyo, Sanofi, Pfizer, all outside the submitted work.

Jul 26, 2024 | medrxiv.org | Krishan Lal Gupta |Felix L. Naegele |Alexander Lu |Rajul K. Ranka

The authors have declared no competing interest. N/A. This study is not a clinical trial. This work was supported by a grant to JPC and KC from the National Institute of Health (RO1 HL148338). I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Jul 24, 2024 | medrxiv.org | Marvin Petersen |Moritz Andreas Link |Carola Mayer |Felix L. Naegele

JG has received speaker fees from Lundbeck, Janssen-Cilag, Lilly, Otsuka and Boehringer outside the submitted work. JF reported receiving personal fees from Acandis, Cerenovus, Microvention, Medtronic, Phenox, and Penumbra; receiving grants from Stryker and Route 92; being managing director of eppdata; and owning shares in Tegus and Vastrax; all outside the submitted work.

Jul 15, 2024 | fis.uke.de | Marvin Petersen |Céleste Chevalier |Felix L. Naegele |Thies Ingwersen

INTRODUCTION: Atrial fibrillation (AF) is associated with an elevated risk of cognitive impairment and dementia. Understanding the cognitive sequelae and brain structural changes associated with AF is vital for addressing ensuing health care needs. METHODS AND RESULTS: We examined 1335 stroke-free individuals with AF and 2683 matched controls using neuropsychological assessments and multimodal neuroimaging.

Dec 23, 2023 | biorxiv.org | Marvin Petersen |Felix Hoffstaedter |Felix L. Naegele |Carola Mayer

AbstractThe link between metabolic syndrome (MetS) and neurodegenerative as well cerebrovascular conditions holds substantial implications for brain health in at-risk populations. This study elucidates the complex relationship between MetS and brain health by conducting a comprehensive examination of cardiometabolic risk factors, cortical morphology, and cognitive function in 40,087 individuals.